LOW MOOR SURGERY — All Prescriptions & Medications — Page 2
Practice Code: B83029 | BRADFORD, BD12 0TH
Showing results 51-100 of 601
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fexofenadine hydrochloride | 964 | 40.5K | £1.8K | +13.4% ▲ |
| Alginic acid compound preparations | 963 | 564.0K | £8.8K | +64.4% ▲ |
| Risedronate sodium | 944 | 4,876 | £1.4K | +678.2% ▲ |
| Dapagliflozin | 942 | 23.3K | £29.0K | -24.8% ▼ |
| Atenolol | 940 | 38.3K | £854 | +55.9% ▲ |
| Venlafaxine | 930 | 28.8K | £5.3K | +10.1% ▲ |
| Linagliptin | 905 | 22.2K | £25.1K | +120.9% ▲ |
| Bendroflumethiazide | 902 | 39.0K | £630 | +16.6% ▲ |
| Rosuvastatin calcium | 892 | 27.5K | £999 | -0.6% vs avg |
| 881 | 1,840 | £64.8K | +61.6% ▲ | |
| Edoxaban | 872 | 22.1K | £36.9K | +24.5% ▲ |
| Ferrous sulfate | 861 | 35.5K | £1.2K | +67.5% ▲ |
| Montelukast | 860 | 20.2K | £988 | +25.6% ▲ |
| Thiamine hydrochloride | 860 | 37.6K | £1.0K | +63.1% ▲ |
| Doxazosin mesilate | 850 | 42.6K | £1.7K | -20.4% ▼ |
| Ibuprofen | 850 | 93.3K | £4.1K | +67.1% ▲ |
| Oxycodone hydrochloride | 847 | 46.9K | £13.1K | +230.9% ▲ |
| 832 | 115.5K | £4.5K | +75.4% ▲ | |
| Digoxin | 831 | 14.3K | £1.1K | +119.6% ▲ |
| Empagliflozin | 831 | 30.3K | £37.6K | +32.8% ▲ |
| Estradiol | 826 | 91.5K | £11.9K | +0.7% vs avg |
| Morphine sulfate | 796 | 74.3K | £4.8K | +21.4% ▲ |
| Prednisolone | 789 | 38.3K | £2.2K | -1.3% vs avg |
| 765 | 11.1K | £8.4K | +15.2% ▲ | |
| Bumetanide | 739 | 18.4K | £2.3K | +171.3% ▲ |
| Duloxetine hydrochloride | 733 | 25.6K | £2.7K | +15.3% ▲ |
| Solifenacin | 711 | 19.7K | £783 | +49.0% ▲ |
| Sildenafil (Erectile Dysfunction) | 704 | 4,946 | £697 | +39.7% ▲ |
| Flucloxacillin sodium | 701 | 30.1K | £1.6K | +55.9% ▲ |
| Other emollient preparations | 695 | 423.3K | £5.8K | +15.7% ▲ |
| Risperidone | 691 | 12.2K | £1.9K | +173.1% ▲ |
| Fluticasone/umeclidinium/vilanterol | 667 | 754 | £31.9K | +184.5% ▲ |
| Quetiapine | 646 | 17.4K | £9.0K | +3.8% ▲ |
| Trazodone hydrochloride | 631 | 17.9K | £901 | +208.7% ▲ |
| Sodium valproate | 620 | 102.9K | £9.3K | +94.9% ▲ |
| Memantine hydrochloride | 613 | 9,678 | £2.4K | +85.6% ▲ |
| 613 | 673 | £919 | +178.2% ▲ | |
| Sacubitril/valsartan | 597 | 16.2K | £26.6K | +149.3% ▲ |
| Biphasic isophane insulin | 597 | 4,205 | £18.2K | +435.1% ▲ |
| 592 | 632 | £27.7K | +90.6% ▲ | |
| Mirabegron | 592 | 15.3K | £14.1K | +47.4% ▲ |
| Nitrofurantoin | 588 | 7,898 | £5.6K | +23.2% ▲ |
| Finasteride | 576 | 16.2K | £595 | -12.0% ▼ |
| Carbamazepine | 571 | 50.4K | £3.7K | +92.4% ▲ |
| Olanzapine | 570 | 9,247 | £1.3K | +53.9% ▲ |
| Donepezil hydrochloride | 563 | 9,184 | £371 | +82.5% ▲ |
| Hydroxocobalamin | 548 | 687 | £1.5K | +13.9% ▲ |
| 548 | 293.6K | £3.4K | +107.7% ▲ | |
| Dihydrocodeine tartrate | 547 | 34.4K | £2.3K | +180.0% ▲ |
| Umeclidinium bromide/vilanterol | 538 | 632 | £19.5K | +175.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.